Published in Vaccine Weekly, October 12th, 2005
Japanese encephalitis (JE) is a mosquito-borne flaviviral infection and the leading cause of viral encephalitis in Asia.
The infection is a major health problem throughout Asia where 3 billion people live in JE-endemic areas. A safe and efficacious traveler vaccine for tourists visiting Asian countries will meet a high unaddressed medical need. The global phase III program consists of a series of immunogenicity and safety trials, and will enroll more than 4900 subjects. Furthermore, a one time vaccination schedule...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly